Last update 08 May 2025
Shanghai Kangjing Biomedical Technology Co., Ltd.

Shanghai Kangjing Biomedical Technology Co., Ltd.

Startups
| Private Company|2017|Shanghai Shi, China|
10-50
|

Overview

Tags

Neoplasms
Immune System Diseases
Nervous System Diseases
Bispecific antibody
Biological products
CRISPR/Cas9

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Bispecific antibody2
CRISPR/Cas91
Antibody fusion proteins1
Biological products1
Nanobody1
Top 5 TargetCount
CD59(CD59 glycoprotein)1
C3 x C3b1

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 11 May 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
5
1
Preclinical
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
CG-001(ComGen)
( C3 x C3b )
Autoimmune Diseases
More
Preclinical
CG011
Neoplasms
More
Discovery
CG016
Neoplasms
More
Discovery
CG101
Autoimmune Diseases
More
Discovery
WO2024051765
( CD59 )
Immune System Diseases
More
Discovery
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free